المؤلفون: Matthias Preusser, Anna Sophie Berghoff, Thorsten Fuereder, Leonhard Müllauer, Gerwin Heller, Angelika Martina Starzer, Katharina Feldmann, Erwin Tomasich, Teresa Hatziioannou, Stefan Traint, Thomas Melchardt, Christoph Minichsdorfer, Ursula Schwarz-Nemec, Maja Nackenhorst

المصدر: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 3 (2022)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://jitc.bmj.com/content/10/3/e003420.full; https://doaj.org/toc/2051-1426

URL الوصول: https://doaj.org/article/e6550fd49f974f6795b61c4497460f1c

المؤلفون: Matthias Preusser, Leonhard Müllauer, Anna S Berghoff, Sebastian Bauer, Gerwin Heller, Thomas Brodowicz, Wolfgang Lamm, Katharina Feldmann, Angelika M Starzer, Rainer Hamacher, Erwin Tomasich, Teresa Hatziioannou, Stefan Traint, Iris M Noebauer-Huhmann, Julia Furtner, Gabriele Amann, Hans-Ulrich Schildhaus

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://jitc.bmj.com/content/9/3/e001458.full; https://doaj.org/toc/2051-1426

URL الوصول: https://doaj.org/article/a79916ad1b1542e9b504874a3913dd32

المؤلفون: Stefan Traint, Sebastian Bauer, Thomas Brodowicz, Gerwin Heller, Katharina Feldmann, Julia Furtner, Gabriele Amann, Rainer Hamacher, Teresa Hatziioannou, Iris M. Noebauer-Huhmann, Leonhard Müllauer, Wolfgang Lamm, Angelika M. Starzer, Erwin Tomasich, Hans-Ulrich Schildhaus, Anna S. Berghoff, Matthias Preusser

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Epigenomics, Male, 0301 basic medicine, Cancer Research, Time Factors, sarcoma, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Medizin, biostatistics, Soft Tissue Neoplasms, Epigenome, 0302 clinical medicine, Germany, Immunotherapy Biomarkers, Tumor Microenvironment, Immunology and Allergy, Immune Checkpoint Inhibitors, RC254-282, Aged, 80 and over, Osteosarcoma, Predictive marker, FOXP3, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Methylation, Middle Aged, Progression-Free Survival, Oncology, CpG site, Austria, 030220 oncology & carcinogenesis, DNA methylation, Molecular Medicine, Female, immunotherapy, Sarcoma, Signal Transduction, Adult, tumor, Immunology, Bone Neoplasms, Young Adult, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, medicine, Humans, Aged, Retrospective Studies, Pharmacology, business.industry, biomarkers, Immunotherapy, DNA Methylation, medicine.disease, Immune checkpoint, 030104 developmental biology, Cancer research, CpG Islands, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::757e63d071fac70057305b1163d6f22a
https://jitc.bmj.com/content/9/3/e001458.full